Esters of pyridine-2,4- and 2,5-dicarboxylic acid as medicaments for the inhibition of proline hydroxylase and lysine hydroxylase
US4717727A · kind A · utility
30Cited by
3References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 29, 1985 |
| Grant date | Jan 5, 1988 |
| Priority date | — |
| Expiry date | Aug 29, 2005 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D213/80
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Esters of pyridine-2,4- and -2,5-dicarboxylic acid act as inhibitors of proline hydroxylase and lysine hydroxylase and are suitable as fibrosuppressants and immunosuppressants, in particular for the treatment of disturbances of the metabolism of collagen and collagen-like substances and of the biosynthesis of Cl.sub.q.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.